Sun Taro Settlement: $200 Million for Generic Drug Buyers, Claims Due November 9, 2026
Questions about this case?
AI Legal Assistant · free · answers in seconds · general information, not legal advice
Sun Pharmaceutical and its subsidiary Taro Pharmaceuticals U.S.A. are paying $200 million to settle claims that they helped inflate generic drug prices. The court granted final approval on January 23, 2026, and the claim form is open. If you paid for one of the listed generic drugs anywhere in the U.S. except Indiana and Ohio between May 1, 2009 and December 31, 2019, you can file — with proof — online or postmarked by November 9, 2026. One claim also covers the $275 million Sandoz settlement.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
What the Sun Taro Lawsuit Is About
The sun taro lawsuit is part of the multidistrict litigation In re Generic Pharmaceuticals Pricing Antitrust Litigation. The lawsuit alleges that generic manufacturers, including Sun and Taro, agreed to fix prices, rig bids and allocate customers for certain generic drugs, so that pharmacy customers and health plans paid more than they should have.
This sun taro class action was brought by “end payers” — people who paid at the pharmacy counter or by mail order, and insurers or self-funded employer plans that reimbursed those prescriptions. Sun and Taro deny any wrongdoing and settled without admitting liability.
Background, not part of this settlement: on July 23, 2020 Taro announced a deferred prosecution agreement with the Justice Department covering conduct from 2013 to 2015, including a payment of $205.7 million, plus a separate framework to pay $213.3 million over federal healthcare program claims. That money went to the government, not to consumers.
Case Details
The case is In re Generic Pharmaceuticals Pricing Antitrust Litigation, MDL No. 2724, No. 2:16-md-02724 in the U.S. District Court for the Eastern District of Pennsylvania, before Judge Cynthia M. Rufe. The end-payer settlement with Sun and Taro is separate from the direct-purchaser Sun and Taro settlements (wholesalers and pharmacies), which Judge Rufe approved on March 9, 2023.
The official website is GenericDrugsEndPayerSettlement.com, phone 1-877-316-0171. The claims administrator is listed as A.B. Data.
Status: Final Approval, Claims Open Until November 9, 2026
As of October 2026, the claim deadline is November 9, 2026 (online, or paper form postmarked by that date). Claims filed after November 9, 2026 are not paid. No payment date has been announced; payments go out after the administrator processes all claims.
The wider case is not over: the lawsuit continues against the manufacturers that have not settled. Our news report on the combined claim form covers the full package of four settlements.
Don't miss the claim deadline
Claims are due by November 9, 2026. We'll email you 7 days and 1 day before the deadline.
Who Can File
You are in the class if you indirectly bought, paid for or reimbursed one or more of the named generic drugs between May 1, 2009 and December 31, 2019, for personal use and not for resale, in any of the 50 states except Indiana and Ohio, or in the District of Columbia, Puerto Rico or the U.S. Virgin Islands.
That covers two groups: consumers who filled prescriptions at a pharmacy or by mail order, and third-party payers such as insurers and self-funded employer health plans.
Excluded: federal and state government entities, Medicaid agencies and consumers whose purchases Medicaid covered, fully insured employers, and pharmacy benefit managers. The list of named drugs is on the official website; check it drug by drug before filing. If you came here about gabapentin, see our gabapentin page.
How Much the Sun Taro Settlement Pays
Proof is required. The claim form must come with supporting documents — receipts or invoices naming the drug, pharmacy account statements, or itemized pharmacy purchase records. Many pharmacies can print a prescription history going back years; ask for one now.
One claim form covers all the end-payer settlements you qualify for. Consumers can draw on the Sun/Taro $200 million and the Sandoz $275 million; the Heritage ($10 million) and Apotex ($48 million) settlements pay health plans only. Together the four make up the $533 million in the court-authorized notice.
How cases like this one end
Our copy of the federal courts’ own case database covers 6,659 antitrust casesclosed in U.S. federal district courts between 2015 and 2025, 37.3% of them filed as class actions:
- 19.7% ended in a settlement recorded by the court. Another 14.4% were dismissed voluntarily, which often follows a private settlement — so the real settlement share sits between 19.7% and 34.1%.
- 11.6% were decided on a motion before any trial.
- 1 in 121 reached a trial (0.8%), after a median of 37 months.
- Median time from filing to the end of the case: 12.3 months.
- Almost none record a money award in this data (32 of 6,659), and the recorded figures are capped, so we do not publish an average.
These are base rates for this type of case (federal antitrust cases) — not a prediction about this lawsuit, and not legal advice. Source: Federal Judicial Center, Integrated Database (civil), analysed by Settlement Insight. Cases heard in state courts are not included.
Sun Taro Settlement Timeline
- 1
July 23, 2020 — Taro Resolves the DOJ Probe
Taro enters a deferred prosecution agreement covering 2013 to 2015 conduct and agrees to pay $205.7 million, plus $213.3 million on federal healthcare program claims.
- 2
March 9, 2023 — Direct-Purchaser Deals Approved
Judge Rufe approves separate Sun and Taro settlements with direct purchasers. Consumers were not part of those deals.
- 3
December 2, 2025 — Opt-Out Deadline Passes
Last day to exclude yourself from or object to the $200 million end-payer settlement.
- 4
January 23, 2026 — Final Approval
After a January 15, 2026 hearing, Judge Rufe grants final approval of the $200 million sun taro settlement.
- 5
July 10, 2026 — Claim Notice Published
A court-authorized notice announces that claims can be filed for $533 million across the Sandoz, Sun/Taro, Heritage and Apotex settlements.
- 6
November 9, 2026 — Claim Deadline
Last day to file online or postmark a paper claim. Payments follow after all claims are processed; no date has been set.
Three Things to Watch For
A big fund, a firm deadline and a proof requirement are what fake helpers count on:
Claims recovery firms that take a cut
The official notice says you do not need to sign up with a claims recovery firm or pay a law firm to take part. Filing at GenericDrugsEndPayerSettlement.com is free.
Look-alike sites asking for your Social Security number
The only official website is GenericDrugsEndPayerSettlement.com, phone 1-877-316-0171. A page with a similar name asking for fees or a full Social Security number to “secure your share” is not the administrator.
“No receipts needed” promises
The official notice requires a claim form with supporting documents. Anyone telling you to just sign a statement is setting you up for a rejected claim — and claims are made under penalty of perjury.
Sun Taro Settlement — Questions People Actually Ask
Is the Sun Taro settlement real?
Yes. It is a $200 million settlement in MDL No. 2724 in the Eastern District of Pennsylvania, with final approval granted by Judge Cynthia M. Rufe on January 23, 2026. Notices pointing you to GenericDrugsEndPayerSettlement.com or 1-877-316-0171 match the court-authorized notice.
What is the deadline to file a Sun Taro claim?
November 9, 2026. File online by that date or mail a paper form postmarked by November 9, 2026. Claims filed later are not paid.
How much will I get?
No one can say yet. Payments are pro rata, based on what you spent on the named drugs between May 1, 2009 and December 31, 2019 and on how many valid claims come in. No per-person estimate has been published.
Do I need proof of purchase?
Yes. The claim form must include supporting documents, such as pharmacy receipts, pharmacy account statements or an itemized prescription history showing the drug and what you paid.
I live in Indiana or Ohio. Can I file?
Not for purchases made in Indiana or Ohio — both states are excluded from the end-payer classes. Purchases made while you lived in another eligible state during the class period can count.
Do I need separate claims for Sun/Taro and Sandoz?
No. One end-payer claim form covers every settlement class you belong to. Consumers can be paid from the Sun/Taro and Sandoz funds; the Heritage and Apotex funds pay health plans only.
I had Medicaid. Am I included?
No. Consumers whose purchases Medicaid covered are excluded, as are Medicaid agencies, government entities, fully insured employers and pharmacy benefit managers.
When will payments arrive?
No date has been set. The administrator distributes payments after it has processed all claims, which cannot happen before the November 9, 2026 deadline passes.
Separate from this case: were you injured in the last 2 years?
Class-action payouts are fixed amounts through an administrator. A personal injury claim is a different case — and often worth far more. Free estimate, no obligation.
Related Consumer Brand Lawsuits
Gabapentin Lawsuit
Gabapentin claims and how they relate to these generic drug cases
Open Class Action Settlements
Settlements taking claims now, sorted by deadline
A.B. Data Settlement Administration
How to tell a real A.B. Data notice from an imitation
Settlement Payout Calculator
Why pro rata payouts depend on how many people file